Pharma News - Chemdiv

Qurient Announces U.S. FDA Clearance of IND Application for Q901, a Novel Cancer Therapy

Qurient Co. Ltd., a clinical stage biotech company, today announced that the U.S. Food and Drug Administration (FDA) has cleared its investigational new drug (IND) application for Q901, a small mol...

Anti-Microbial Nasal Spray Effective Against COVID-19 in Nonhospitalized Patients, Study Shows

Glenmark Pharmaceuticals reported that its anti-microbial nitric oxide nasal spray (NONS) had positive results in a phase 3 trial in 306 nonhospitalized adult Indian patients with COVID-19. ...

Lupin’s Generic Bronchoconstriction Medicine Gains FDA Approval

Indian generic drugmaker Lupin got FDA approval for its nebulization-only medicine for long-term maintenance of bronchoconstriction in patients with chronic obstructive pulmonary disease (COPD), in...

FDA may halt approval on cancer drugs developed in China

Drugs produced in China account for a significant share of the US market.

Receives Orphan Drug Designation for Retinoblastoma from the U.S. FDA

Synthetic Biologics, Inc., a diversified clinical-stage company developing therapeutics designed to treat diseases in areas of high unmet need, today announced that VCN Biosciences, S.L.'s (VCN) V...

Texas’ $225 million opioid settlement is biggest to date for generic drugmaker

The deal includes $150 million of cash payments over 15 years and $75 million of the overdose-fighting medication Narcan (Naloxone).

Drug halts immune reactions to save damaged lungs

A team of scientists led by Cold Spring Harbor Laboratory (CSHL) have discovered that disulfiram, an FDA-approved drug, prevents the immune system from producing toxic webs known as neutrophil ext...

Valneva, Pfizer Lyme disease vaccine candidate to enter Phase 3 testing following positive immune showings

Phase 2 testing of a Lyme disease vaccine candidate, VLA15, produced strong immune responses, according to the newest data from Valneva SE and Pfizer inc, prompting preparations for a Phase 3 study...

Wistar scientists move HIV vaccine research forward by developing an immunogen that produces tier-2 antibodies—the kind that matter for combatting HIV

The vaccine delivery system uses DNA to encode genetic instruction in vivo, producing a more efficacious immune response.

Covid medications help big pharma groups beat expectations

Covid was the common currency as three top pharma groups reported results.

Bayer will discontinue phase II development candidate eliapixant

Review of development program led to reassessment of benefit-risk ratio in all four potential indications for the investigational P2X3 receptor antagonist.

Eli Lilly Delays Application for Experimental Alzheimer’s Drug

Eli Lilly said it will hold off on seeking accelerated approval of its investigational Alzheimer’s drug, donanemab, until later this year, rather than completing filing during the first quarter a...